help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maggi, R.
Right arrow Articles by Piva, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maggi, R.
Right arrow Articles by Piva, F.

Endocrinology, Vol 136, 289-295, Copyright © 1995 by Endocrine Society


ARTICLES

Characterization of functional opioid delta receptors in a luteinizing hormone-releasing hormone-producing neuronal cell line

R Maggi, F Pimpinelli, L Martini and F Piva
Department of Endocrinology, University of Milan, Italy.

Endogenous opioids participate in the regulation of gonadotropin secretion through an influence on the release of the hypothalamic LHRH. However, it is not clear whether opioids exert a direct effect on LHRH- producing neurons or interfere with other systems able to influence LHRH release. A neuronal LHRH-producing cell line (GT1) developed recently provides a good model to study the mechanisms controlling LHRH release. In the present study, the presence of opioid receptors on a subclone of GT1 cells (GT1-1) has been investigated. A specific and saturable binding of the 3H-labeled nonselective opioid ligand diprenorphine ([3H]DIP) was detected by a receptor binding assay on both intact GT1-1 cells and crude membrane preparations obtained from these cells. Analysis of saturation curves revealed that [3H]DIP apparently binds to a single class of sites with a Kd of 0.2 nM and a binding capacity of 125 fmol/mg protein, corresponding to approximately 20,000 sites/cell. Selective displacement of the binding of [3H]DIP to GT1-1 cells by [D-Ala2,N-Me-Phe4,Gly5-ol]enkephalin, [D-Pen2,D- Pen5]enkephalin (DPDPE), and U50488H, which are selective ligands, respectively, for mu-, delta-, and kappa-receptors, was also evaluated. Only the specific delta-ligand DPDPE produced a significant inhibition of the binding of [3H]DIP. [D-Ala2,N-Me-Phe4,Gly5-ol]Enkephalin and U50488H were totally ineffective. The inhibitory effect of the agonist DPDPE on the binding of [3H]DIP was decreased by the presence of sodium ions, a typical characteristic of the binding of agonists to opioid receptors. Finally, it has been observed that treatment with prostaglandins E1 and E2 produces a dramatic increase in cAMP accumulation in GT1-1 cells, and DPDPE is highly effective in suppressing this effect. On the basis of these results, it is possible to postulate the presence of functional delta-opioid receptors on GT1-1 cells. By extrapolation, one might suggest that endogenous opioids may affect LHRH neurons by two mechanisms: a direct one, acting via delta- receptors, and an indirect one, through the activation of neurons impinging on the LHRH system, which uses mu-receptors.


This article has been cited by other articles:


Home page
J. Physiol.Home page
J. E Bowe, X. F Li, J. S Kinsey-Jones, S Paterson, S. D Brain, S. L Lightman, and K. T O'Byrne
Calcitonin gene-related peptide-induced suppression of luteinizing hormone pulses in the rat: the role of endogenous opioid peptides
J. Physiol., August 1, 2005; 566(3): 921 - 928.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
R. B. Perkins, J. E. Hall, and K. A. Martin
Neuroendocrine Abnormalities in Hypothalamic Amenorrhea: Spectrum, Stability, and Response to Neurotransmitter Modulation
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 1905 - 1911.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
F. Pimpinelli, G. E. Rovati, V. Capra, F. Piva, L. Martini, and R. Maggi
Expression of Prostacyclin Receptors in Luteinizing Hormone-Releasing Hormone Immortalized Neurons: Role in the Control of Hormone Secretion
Endocrinology, January 1, 1999; 140(1): 171 - 177.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
G. K. Bhat, V. B. Mahesh, L. Ping, L. Chorich, V. T. Wiedmeier, and D. W. Brann
Opioid-Glutamate-Nitric Oxide Connection in the Regulation of Luteinizing Hormone Secretion in the Rat
Endocrinology, March 1, 1998; 139(3): 955 - 960.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. I. Sannella and S. L. Petersen
Dual Label in Situ Hybridization Studies Provide Evidence that Luteinizing Hormone-Releasing Hormone Neurons Do Not Synthesize Messenger Ribonucleic Acid for {micro}, {kappa}, or {delta} Opiate Receptors
Endocrinology, April 1, 1997; 138(4): 1667 - 1672.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
K. M. Ogilvie and C. Rivier
Effect of Alcohol on the Proestrous Surge of Luteinizing Hormone (LH) and the Activation of LH-Releasing Hormone (LHRH) Neurons in the Female Rat
J. Neurosci., April 1, 1997; 17(7): 2595 - 2604.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1995 by The Endocrine Society